Ralf Schmidt

Ralf Schmidt is an accomplished business development leader with extensive experience in the pharmaceutical and healthcare industries. Currently serving as the Head of Global Business Development for Abbott's Established Pharmaceuticals Division, Ralf oversees acquisitions, licensing, and external partnerships. Previous roles include Head of Business Development EMEA at Kenvue, where significant contributions included the development of the corporate strategy and completion of key transactions post-spin-off. At Johnson & Johnson, Ralf held the position of Senior Director for EMEA Business Development in Consumer Health, managing over $5 billion in strategic initiatives. Ralf's tenure at Novartis involved leading global M&A efforts at Sandoz, completing numerous projects with a combined investment of approximately $3 billion. Additionally, Ralf has held senior roles at Merck Group and Deutsche Bank, showcasing a robust background in M&A strategy and execution. Ralf holds an MBA from Harvard Business School and a Diplom in Food Science from Kiel University.